Nautilus Neuroscience's Series A - II Round

Nautilus Neuroscience raised a round of funding on January 07, 2010. Investors include Tailwind Capital Partners.

Nautilus Neurosciences is a neurology-focused specialty pharmaceutical company committed to providing the healthcare community with relevant products and services that directly benefit those affected …

Articles about Nautilus Neuroscience's Series A - II Round: